Trinity Biotech (TRIB) Retained Earnings (2009 - 2025)
Trinity Biotech (TRIB) posted quarterly Retained Earnings of -$116.2 million for Q4 2025, down 46.83% year-on-year from -$218.5 million in Q4 2024, and down 505182.61% on a QoQ basis from $23000.0 in Q2 2025.
Trinity Biotech (TRIB) Retained Earnings (2009 - 2025) Analysis & Trends
Trinity Biotech (TRIB) has reported Retained Earnings for 17 consecutive years, with -$116.2 million the latest figure, recorded in Q4 2025.
- Quarterly Retained Earnings fell 46.83% year-over-year to -$116.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$116.2 million (down 46.83% YoY) and the FY2025 annual result came in at -$116.2 million, down 46.83% from the prior year.
- Retained Earnings eased to -$116.2 million in Q4 2025 per TRIB's latest filing, from $23000.0 in the prior quarter.
- Over the last five years, Retained Earnings for TRIB reached as high as $86000.0 in Q4 2022 and fell as low as -$116.2 million in Q4 2025.
- A 5-year average of -$10.8 million and a median of $23000.0 in 2021 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2022 — Retained Earnings surged 273.91% — and 2024, when it slumped 344086.96%.
- Year by year, Retained Earnings stood at $23000.0 in 2021, then jumped by 273.91% to $86000.0 in 2022, then slumped by 73.26% to $23000.0 in 2023, then sank by 344086.96% to -$79.1 million in 2024, then plunged by 46.83% to -$116.2 million in 2025.
- According to Business Quant data, Retained Earnings over the past three periods registered -$116.2 million, $23000.0, and -$79.1 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -6.31 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -583.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -4.10 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 6.91 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 14.62 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.63 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -1.40 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 5.32 Bn |
| 10 | Trinity Biotech | 93,750.00 | -5.04 Mn | - | -116.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -116.17 Mn |
| Jun 30, 2025 | 23,000.00 |
| Dec 31, 2024 | -79.12 Mn |
| Sep 30, 2024 | 23,000.00 |
| Jun 30, 2024 | 23,000.00 |
| Mar 31, 2024 | 23,000.00 |
| Dec 31, 2023 | 23,000.00 |
| Sep 30, 2023 | 23,000.00 |
| Jun 30, 2023 | 23,000.00 |
| Mar 31, 2023 | 23,000.00 |
| Dec 31, 2022 | 86,000.00 |
| Sep 30, 2022 | 23,000.00 |
| Jun 30, 2022 | 23,000.00 |
| Mar 31, 2022 | 23,000.00 |
| Dec 31, 2021 | 23,000.00 |
| Sep 30, 2021 | 23,000.00 |
| Jun 30, 2021 | 23,000.00 |
| Mar 31, 2021 | 23,000.00 |
| Dec 31, 2020 | 23,000.00 |
| Sep 30, 2020 | -25.99 Mn |